Meet us at MDIC | 16-17th April 2024 in Washington DC

Meet us at MDIC

The Future of Healthcare: How Personalized Medicine is Becoming a Market Imperative


Have you ever imagined visiting your doctor and seeing a digital clone of yourself as a 3D model on the computer screen? Envision your doctor explaining a simulation of the surgery or treatment that awaits you in detail on your digital twin.

The Healthcare Industry experiences a Conceptual Shift 

The above-described stage of personalized medicine may sound utopian, but developing a comprehensive digital representation of the human body is highly complex. Also, it comes with various security and ethical considerations [1].   

However, the market for personalized medicine will grow in the coming years due to various factors, including the rising incidence of chronic diseases, the aging global population, and the increasing number of cancer types. Precedence Research projects that the personalized medicine market will reach USD 1.23 trillion by 2033, with a CAGR* of 8.10% from 2024 to 2033, as visualized in the graph below [2].

Personalized medicine, no longer restricted to drugs, is now adopting a new approach of tailoring treatment to each patient’s anatomical and physiological features. The advancing technology and capabilities of personalized medicine fuel this significant transformation. 

Simq is contributing to this market development with a clear mission: To accelerate the adoption of personalized patient care through simulation. 

Don’t hesitate to involve your medical business in this market shift, and book your free consultation with us today!

Personalized Medicine is advancing in the Digital World

As humanity progresses in healthcare, personalized medicine presents a promising prospect for enhancing patient care, streamlining treatment processes, and significantly improving health outcomes. This personalization trend marks a pivotal shift from the traditional healthcare model to a more targeted and effective paradigm. Advances in information technology and computer-aided engineering have enabled a new approach to healthcare.

Simq specializes and pioneers in physics-based, patient-specific approaches, provides software solutions to optimize patient care and offers development and consulting services to medical device manufacturers. In this context, personalized medicine refers to a collection of medical simulations, also known as in silico methods, that construct and sustain digital patient twins

By leveraging in silico methods, healthcare professionals can predict outcomes more accurately and develop treatments specifically suited to the patient’s unique physiological and genetic makeup. This approach enhances the efficacy of treatments and significantly reduces the time and cost associated with traditional clinical trials.

How Personalized Medicine is Beneficial for Humanity

The use of computer-aided modeling and simulation in personalized medicine has numerous advantages. It helps medical device manufacturers save time and cost, provides innovative treatment options, and allows for tailored and safer patient care. The main three advantages are:

  1. Cost and Time Savings: Virtual simulation can replace animal and human trials. For medical devices it can shorten the approval process and thus reduce its costs.
  1. Innovation Enhancement: Digital experiments enable innovative treatments, methods or devices that might not be possible otherwise.
  1. Personalized and Safer Patient Care: Tailoring treatments to fit individual patient’s needs can result in less invasive procedures, shorter treatment times, and better implant tolerability. Personalized treatment reduces the risk of implant failure and enhances patient care quality.

Virtual Approaches to Medical Device Approvals 

Virtual testing and development facilitates the creation of treatments that are unique to each patient. One prime example of this approach is Simq VIT, which allows for the digital verification of personalized implants. This ensures that patients receive optimal outcomes while enhancing the safety and quality of medical devices. In future, medical devices could potentially be widely approved by deploying digital approval methods. 

Our Simq VIT Dental Workflow software makes it easier, faster and more secure to verify the design of patient-specific implants (PSIs) digitally. This reduces liability while improving the implant quality by providing an objective set of criteria to both the clinician and the design team. Medical professionals who apply personalized medicine will have a competitive market advantage in the upcoming decades due to its benefits.

In the screenshot below a customized jaw implant verification can be seen, and the resulting screw forces are displayed in the digital model. Simq VIT is an excellent choice for custom jaw implant verification due to its unparalleled speed and efficiency in the verification process. Find out more in this Simq VIT success story with KLS Martin Group

Simq VIT also helps meet regulatory requirements through virtual testing and automated report generation following MDR and FDA guidelines. The system optimizes material handling, contributing to product quality enhancement. Manufacturers can offer extended warranties, which raises long-term trust and enhances customer satisfaction. 

Regulatory requirements for medical devices are also expected to become more stringent to improve device safety and efficacy. Additionally, the trend towards digital evidence promoted by the FDA will likely gain momentum, resulting in increased use of simulations and artificial intelligence (AI) during medical device approvals.

Improved Diagnosis and Therapies through Digital Methods

Simulation-based techniques are expected to play a vital role not only in diagnosing medical conditions but also in assisting with therapy and planning. One potential example of this is Simq OSA, which aims to optimize the diagnosis of obstructive sleep apnea (OSA) using patient-specific data and numerical flow simulation. This technology can support the treating physician in finding the most suitable therapy for the respective patient.

Another technology that is already in use is Simq RPE, which is a preoperative simulation-based planning tool for forced palatal expansion. Here, simulation-based methods are used to specifically optimize the surgical incision in order to achieve a symmetrical result for all patients. 

Our client, KLS Martin Group, has already implemented several applications from Simq to their advantage. Learn how KLS Martin Group successfully integrated Simq RPE into their existing processes. The schematics below summarize the solution behind RPE to tackle the risk of asymmetric widening results through rapid palatal expansion.

Simq’s software products are all centered around personalized medicine. We use numerical simulation on the Simq platform to explore personalized patient treatment. Our Simq products allow medical professionals to utilize complex numerical simulations with patient data such as CT or MRI scans. Medical simulation can generate quality management reports for medical device manufacturers and physicians, and support post-market surveillance with objective data. 

Simq is a certified simulation service provider and software manufacturer in the field of medical technology, committed to safety, data security and affordable healthcare through the standardization and broader application of in silico medicine.

Personalized Healthcare is a Pioneering Field of Hope

In-silico methods and simulation-based optimization can pave the way for a more personalized and efficient approach to medicine. Personalized Medicine opens huge opportunities for all human beings by improving the whole healthcare sector. Medical businesses, healthcare professionals, patients and even animals will benefit during the next decades from the developments and efforts with the goal of personalizing medicine. 

Simq, as a leading company shaping the future of healthcare, is at the forefront of this vision: Our combination of cutting-edge and established technologies sets new standards in patient care, improves processes and outcomes, and ultimately benefits the entire healthcare system.

🔗 Book your free consultation today

Sources:

[1] https://www.sciencedirect.com/science/article/pii/S2666990021000136

[2] https://www.precedenceresearch.com/personalized-medicine-market

* CAGR – Compound Annual Growth Rate: the rate at which an economy, investment, company, etc. grows over a period of years, based on growth over the previous year https://dictionary.cambridge.org/de/worterbuch/englisch/compound-growth-rate